NCT07232823

Brief Summary

The purpose aims to assess the efficacy of Brief Culturally Adapted Cognitive Behaviour Therapy (Ca-CBT) for the treatment of Obsessive Compulsive Disorder (OCD).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
166

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

October 20, 2024

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

November 18, 2025

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2025

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

November 18, 2025

Status Verified

November 1, 2025

Enrollment Period

1.1 years

First QC Date

October 16, 2024

Last Update Submit

November 15, 2025

Conditions

Keywords

CBTCaCBTOCD

Outcome Measures

Primary Outcomes (2)

  • Efficacy of brief culturally adapted cognitive behaviour therapy (CaCBT) for OCD

    By comparing pre- and post-treatment OCD scores measured through the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS).

    6 weeks

  • Acceptability of the brief culturally adapted cognitive behaviour therapy (CaCBT) for OCD

    Feedback will be taken from both patients and their family members, who will be trained as co-therapists, to evaluate their satisfaction with the therapy.

    6 weeks

Secondary Outcomes (2)

  • Reduction in depression and anxiety associated with OCD

    6 weeks

  • Reduction in functioning decline associated with OCD

    6 weeks

Study Arms (2)

Brief culturally adapted CBT (CaCBT) group

EXPERIMENTAL

Participants in this group will receive the Culturally Adapted CBT (CaCBT) manual along with treatment as usual (which typically involves medication prescriptions and regular hospital visits). The manual will focus on psychoeducation, symptom management, Exposure and Response prevention (ERP), thought distraction techniques, relaxation exercises, detection of mood and thoughts, cognitive errors, changing negative thinking, behavioural activation, problem solving, improving relationships and communication skills, Thought diaries and progress diary.

Other: Brief culturally adapted cognitive behaviour therapy (CaCBT)

Treatment as usual group

NO INTERVENTION

Participants in this group will receive only treatment as usual (TAU), which typically involves medication prescriptions and regular hospital visits. Research psychologists delivering the intervention will not be involved with participants allocated to TAU.

Interventions

The intervention will focus on psychoeducation, symptom management, Exposure and Response prevention (ERP), thought distraction techniques, relaxation exercises, detection of mood and thoughts, cognitive errors, changing negative thinking, behavioural activation, problem solving, improving relationships and communication skills, Thought diaries and progress diary.

Brief culturally adapted CBT (CaCBT) group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants aged 18 years or above
  • Participants with at least an elementary level of reading and writing
  • Clinical diagnosis of Obsessive Compulsive Disorder, either alone or comorbid with depression or anxiety

You may not qualify if:

  • Participants with excessive use of alcohol or drugs (using ICD-10 RDC for alcohol or drug abuse or dependence)
  • Those with significant cognitive impairment (for example, intellectual disability or dementia)
  • Or those with OCD comorbid active psychosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Professional Association of Cognitive Therapy

Lahore, Punjab Province, 54000, Pakistan

RECRUITING

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • Farooq Naeem

    Professional Association of Cognitive Therapy

    PRINCIPAL INVESTIGATOR
  • Muhammad Aslam

    Professional Association of Cognitive Therapy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: This will be a randomised, controlled, assessor-blind clinical trial. It will be carried out at Recovery Psychiatric \& Addiction Treatment, Rehab \& Psychotherapy Centre, Lahore, and Dr Muhammad Afzal Khan Clinic, Faisalabad. The participants will be provided with oral and written information about the study, and written informed consent will be obtained. Participants who agree to participate will be allocated to one of the groups: brief CaCBT plus TAU (Treatment group) or TAU alone (Control group).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2024

First Posted

November 18, 2025

Study Start

October 20, 2024

Primary Completion

December 10, 2025

Study Completion

December 31, 2025

Last Updated

November 18, 2025

Record last verified: 2025-11

Locations